Literature DB >> 11807618

Influence of antithyroid drugs on the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre.

O Sabri, M Zimny, U Buell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11807618     DOI: 10.1007/s00259-001-0673-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

1.  [Reduced antithyroid agents as a result of radioiodine therapy?].

Authors:  D Maka; H Schicha; C Körber; P Schneider; C Reiners
Journal:  Nuklearmedizin       Date:  2000       Impact factor: 1.379

2.  Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.

Authors:  O Sabri; M Zimny; M Schreckenberger; P Reinartz; E Ostwald; U Buell
Journal:  Thyroid       Date:  1999-12       Impact factor: 6.568

3.  [Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].

Authors:  V Urbannek; E Voth; D Moka; H Schicha
Journal:  Nuklearmedizin       Date:  2001-08       Impact factor: 1.379

4.  [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].

Authors:  O Sabri; M Zimny; M Schreckenberger; P Reinartz; B Nowak; E Ostwald; W Schäfer; S Block; K Setani; U Büll
Journal:  Nuklearmedizin       Date:  2001-02       Impact factor: 1.379

5.  Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication.

Authors:  O Sabri; M Zimny; G Schulz; M Schreckenberger; P Reinartz; K Willmes; U Buell
Journal:  J Clin Endocrinol Metab       Date:  1999-04       Impact factor: 5.958

6.  Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?

Authors:  C Körber; P Schneider; N Körber-Hafner; H Hänscheid; C Reiners
Journal:  Eur J Nucl Med       Date:  2001-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.